208 related articles for article (PubMed ID: 31128096)
1. Sex differences in mixed neuropathologies in community-dwelling older adults.
Barnes LL; Lamar M; Schneider JA
Brain Res; 2019 Sep; 1719():11-16. PubMed ID: 31128096
[TBL] [Abstract][Full Text] [Related]
2. TDP-43 stage, mixed pathologies, and clinical Alzheimer's-type dementia.
James BD; Wilson RS; Boyle PA; Trojanowski JQ; Bennett DA; Schneider JA
Brain; 2016 Nov; 139(11):2983-2993. PubMed ID: 27694152
[TBL] [Abstract][Full Text] [Related]
3. Cognitive impairment, decline and fluctuations in older community-dwelling subjects with Lewy bodies.
Schneider JA; Arvanitakis Z; Yu L; Boyle PA; Leurgans SE; Bennett DA
Brain; 2012 Oct; 135(Pt 10):3005-14. PubMed ID: 23065790
[TBL] [Abstract][Full Text] [Related]
4. Sex differences in Alzheimer's disease and common neuropathologies of aging.
Oveisgharan S; Arvanitakis Z; Yu L; Farfel J; Schneider JA; Bennett DA
Acta Neuropathol; 2018 Dec; 136(6):887-900. PubMed ID: 30334074
[TBL] [Abstract][Full Text] [Related]
5. TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.
McAleese KE; Walker L; Erskine D; Thomas AJ; McKeith IG; Attems J
Brain Pathol; 2017 Jul; 27(4):472-479. PubMed ID: 27495267
[TBL] [Abstract][Full Text] [Related]
6. Mixed pathology is more likely in black than white decedents with Alzheimer dementia.
Barnes LL; Leurgans S; Aggarwal NT; Shah RC; Arvanitakis Z; James BD; Buchman AS; Bennett DA; Schneider JA
Neurology; 2015 Aug; 85(6):528-34. PubMed ID: 26180136
[TBL] [Abstract][Full Text] [Related]
7. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of TDP-43 proteinopathy and hippocampal sclerosis in relation to APOE ε4 haplotype status: a community-based cohort study.
Yang HS; Yu L; White CC; Chibnik LB; Chhatwal JP; Sperling RA; Bennett DA; Schneider JA; De Jager PL
Lancet Neurol; 2018 Sep; 17(9):773-781. PubMed ID: 30093249
[TBL] [Abstract][Full Text] [Related]
9. Aging and cerebrovascular lesions in pure and in mixed neurodegenerative and vascular dementia brains: a neuropathological study.
De Reuck J; Maurage CA; Deramecourt V; Pasquier F; Cordonnier C; Leys D; Bordet R
Folia Neuropathol; 2018; 56(2):81-87. PubMed ID: 30509027
[TBL] [Abstract][Full Text] [Related]
10. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson's disease dementia.
Hansen D; Ling H; Lashley T; Foley JA; Strand C; Eid TM; Holton JL; Warner TT
Neuropathol Appl Neurobiol; 2021 Feb; 47(1):143-156. PubMed ID: 32720329
[TBL] [Abstract][Full Text] [Related]
11. Lewy body-related alpha-synucleinopathy in the aged human brain.
Jellinger KA
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
[TBL] [Abstract][Full Text] [Related]
12. The Role of Alzheimer's and Cerebrovascular Pathology in Mediating the Effects of Age, Race, and Apolipoprotein E Genotype on Dementia Severity in Pathologically-Confirmed Alzheimer's Disease.
Gavett BE; John SE; Gurnani AS; Bussell CA; Saurman JL
J Alzheimers Dis; 2016; 49(2):531-45. PubMed ID: 26444761
[TBL] [Abstract][Full Text] [Related]
13. Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.
Robinson JL; Corrada MM; Kovacs GG; Dominique M; Caswell C; Xie SX; Lee VM; Kawas CH; Trojanowski JQ
Acta Neuropathol; 2018 Sep; 136(3):377-388. PubMed ID: 29916037
[TBL] [Abstract][Full Text] [Related]
14. Alzheimer's disease neuropathologic change, Lewy body disease, and vascular brain injury in clinic- and community-based samples.
Brenowitz WD; Keene CD; Hawes SE; Hubbard RA; Longstreth WT; Woltjer RL; Crane PK; Larson EB; Kukull WA
Neurobiol Aging; 2017 May; 53():83-92. PubMed ID: 28236716
[TBL] [Abstract][Full Text] [Related]
15. Clinical Features of Alzheimer Disease With and Without Lewy Bodies.
Chung EJ; Babulal GM; Monsell SE; Cairns NJ; Roe CM; Morris JC
JAMA Neurol; 2015 Jul; 72(7):789-96. PubMed ID: 25985321
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and pathology of dementia with Lewy bodies in the oldest old: a comparison with other dementing disorders.
Jellinger KA; Attems J
Dement Geriatr Cogn Disord; 2011; 31(4):309-16. PubMed ID: 21502762
[TBL] [Abstract][Full Text] [Related]
17. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
[TBL] [Abstract][Full Text] [Related]
18. Impact of multiple pathologies on the threshold for clinically overt dementia.
Kapasi A; DeCarli C; Schneider JA
Acta Neuropathol; 2017 Aug; 134(2):171-186. PubMed ID: 28488154
[TBL] [Abstract][Full Text] [Related]
19. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
20. The neuropathology of older persons with and without dementia from community versus clinic cohorts.
Schneider JA; Aggarwal NT; Barnes L; Boyle P; Bennett DA
J Alzheimers Dis; 2009; 18(3):691-701. PubMed ID: 19749406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
